Form D · Biotechnology
Celldex Therapeutics, Inc.
Hampton, NJ · CIK 000744218
Offering snapshot reported Oct 24, 2014 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2014 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227106
Shares to be issued pursuant to Supply Agreement
Source: Form D, filed Oct 24, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Avery W. Catlin | Executive |
| Herbert J. Conrad | Director |
| Larry Ellberger | Director |
| George O. Elston | Director |
| Anthony S. Marucci | Director, Executive |
| Harry H. Penner, Jr. | Director |
| Timothy M. Shannon, M. D. | Director |
| Karen Shoos | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
53 Frontage Road, Suite 220
Hampton, NJ, 08827
Hampton, NJ, 08827